Inovio Pharmaceuticals
INO
INO
211 hedge funds and large institutions have $682M invested in Inovio Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 68 increasing their positions, 46 reducing their positions, and 47 closing their positions.
Holders
211
Holders Change
-7
Holders Change %
-3.21%
% of All Funds
3.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
41
Increased
68
Reduced
46
Closed
47
Calls
$33.9M
Puts
$37.2M
Net Calls
-$3.28M
Net Calls Change
+$2.32M
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$31.9M |
| 2 |
2
D.E. Shaw & Co
New York
|
$19.4M |
| 3 |
3
Goldman Sachs
New York
|
$12.1M |
| 4 |
4
BlackRock
New York
|
$168M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$82.6M |
